Moxetumomab Pasudotox-tdfk and Remifentanil Intravenous
Determining the interaction of Moxetumomab Pasudotox-tdfk and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Reminyl
- Moxetumomab Pasudotox-tdfk-Reminyl ER
- Moxetumomab Pasudotox-tdfk-Remodulin
- Moxetumomab Pasudotox-tdfk-Remodulin injection
- Moxetumomab Pasudotox-tdfk-Remular-S
- Moxetumomab Pasudotox-tdfk-Renacidin
- Remifentanil Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Remifentanil Intravenous-Moxifloxacin
- Remifentanil Intravenous-Moxifloxacin (Systemic)
- Remifentanil Intravenous-Moxifloxacin Hydrochloride
- Remifentanil Intravenous-Moxifloxacin Injection
- Remifentanil Intravenous-Moxifloxacin Intravenous